Innovative, Articulate, and Easy to Follow: A Professional Rewrite of Glancy Prongay Murray LLP Reminds Investors of Looming Deadline in Class Action Lawsuit Against Vintage Wine Estates Inc. (VWE)

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Vintage Wine Estates, Inc. (VWE) LOS ANGELES, Nov. 28, 2022 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 13, 2023 deadline to file a lead plaintiff motion in the class action filed…

Read More

Get Ready to Say Goodbye to Pain: Double Rainbow Unveils the World’s First Commercial-Scale Biosynthetic Gastrodin – A Natural Pain Reliever with Endless Possibilities!

The global Gastrodin market is expected to rise significantly over the next five years Double Rainbow Announces World’s First Commercial-Scale Biosynthetic Gastrodin, a Natural Marvel Lexington, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) — DoubleRainbow Biosciences (“Double Rainbow”), a sustainable biotech company harnessing bioengineering to improve the quality of human health, today announced the world’s first…

Read More

Breaking News: BioCryst’s Orladeyo (Berotralstat) Receives Approval from Israeli Ministry of Health

BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Israeli Ministry of Health RESEARCH TRIANGLE PARK, N.C., Nov. 28, 2022 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Israeli Ministry of Health has granted marketing authorization for oral, once-daily ORLADEYO® (berotralstat) to prevent attacks of hereditary angioedema (HAE) in adults and pediatric…

Read More

Breaking Ground in Cystic Fibrosis Treatment: Nabriva Therapeutics’ Xenleta (Lefamulin) Phase 1 Trial Yields Promising Results

Nabriva Therapeutics Announces Positive Topline Results from Phase 1 Trial of XENLETA® (lefamulin) in Adult Patients PK Data and Safety Profile Consistent with Previous Studies in Healthy Subjects Results Support Potential Utility of Lefamulin in Patients with Cystic Fibrosis DUBLIN, Ireland and FORT WASHINGTON, Pa., Nov. 28, 2022 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ:…

Read More

Unlocking the Potential: High Performance Fiber Market Projected to Reach USD 25 Billion by 2030 with 8% CAGR – Insights from Market Research Future (MRFR)

High-Performance Fiber Market Insights and Industry Analysis High-Performance Fiber Market Overview The high-performance fiber market is projected to experience significant growth in the coming years, with a forecasted market size reaching USD 25 billion by 2030 at a CAGR of 8%. Various types of high-performance fibers are driving this growth, including carbon fiber, aramid fiber,…

Read More

Revolutionizing the Crypto World: B2C2 Utilizes Kx’s Real-Time Analytics Software and Introduces Cutting-Edge Visualization Tool

B2C2 Expands Use of KX’s Real-Time Analytics Software, Deploys Visualization Tool A New Partnership for Success It’s always exciting when two industry leaders come together to collaborate on a project that will undoubtedly shape the future of digital assets markets. The recent partnership between B2C2 and KX is a testament to the power of innovation…

Read More